HTLV-2 infection in injection drug users in King County, Washington

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 8, 2006, Pages 654-663

  Zunt, Joseph ^a   Tapia, Ken ^a   Thiede, Hanne ^b   Lee, Rong ^b   Hagan, Holly ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RACE; SEROCONVERSION; SERODIAGNOSIS; TATTOO; UNITED STATES; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; FEMALE; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE, INTRAVENOUS; WASHINGTON;

EID: 33746656193     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600617009     Document Type: Article

References (32)

1. Feigal, E and Murphy, E and Vranizan, K and Bacchetti, P and Chaisson, R and Drummond, JE and (1991) Human T-cell lymphotropic virus types I and II in intravenous drug users in San Francisco: Risk factors associated with seropositivity J Infect Dis, 164, pp. 36-42.
2. Khabbaz, RF and Onorato, IM and Cannon, RO and Hartley, TM and Roberts, B and Hosein, B and (1992) Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases N Engl J Med, 326, pp. 375-80.
3. Schwebke, J and Calsyn, D and Shriver, K and Saxon, A and Kleyn, J and Oluoch-Mitchell, E and (1994) Prevalence and epidemiologic correlates of human T-cell lymphotropic virus infection among intravenous drug users J Infect Dis, 169, pp. 962-7.
4. Thiede, H and Harris, NV and McGough, JP and Roberts, B and Khabbaz, RF and Kaplan, JE. (1994) Prevalence of HTLV types I and II among drug users in King County, Washington West J Med, 160, pp. 540-4.
5. Dourado, I and Andrade, T and Carpenter, CL and Galvao-Castro, B. (1999) Risk factors for human T-cell lymphotropic virus type I among injecting drug users in north-east Brazil: Possibly greater efficiency of male to female transmission Mem Inst Oswaldo Cruz, 94, pp. 13-8.
6. Fuente, LD and Toro, C and Soriano, V and Brugal, MT and Vallejo, F and Barrio, G and (2005) HTLV infection among young injection and non-injection heroin users in Spain: Prevalence and correlates J Clin Virol, 35, pp. 244-9.
7. Krook, A and Albert, J and Andersson, S and Biberfeld, G and Blomberg, J and Eklund, I and (1997) Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994 J Acquir Immune Defic Syndr Hum Retrovirol, 15, pp. 381-6.
8. Vlahov, D and Khabbaz, RF and Cohn, S and Galai, N and Taylor, E and Kaplan, JE. (1995) Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, USA J Acquir Immune Defic Syndr Hum Retrovirol, 9, pp. 89-96.
9. Maloney, EM and Armien, B and Gracia, F and Castillo, L and Kruger, H and Levin, A and (1999) Risk factors for human T-cell lymphotropic virus type II infection among the Guaymi Indians of Panama J Infect Dis, 180, pp. 876-9.
10. Murphy, EL and Fridey, J and Smith, JW and Engstrom, J and Sacher, RA and Miller, K and (1997) HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators Neurology, 48, pp. 315-20.
11. Murphy, EL and Glynn, SA and Fridey, J and Fridey, J and Sacher, RA and Smith, JW and Wright, DJ and (1997) Increased prevalence of infectious diseases and other adverse outcomes in human T-lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group J Infect Dis, 176, pp. 1468-75.
12. Castillo, LC and Gracia, F and Roman, GC and Levine, P and Reeves, WC and Kaplan, J. (2000) Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/HTLV-II): Report of 3 cases from Panama Acta Neurol Scand, 101, pp. 405-12.
13. Jacobson, S and Lehky, T and Nishimura, M and Robinson, S and McFarlin, DE and Dhib-Jalbut, S. (1993) Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis Ann Neurol, 33, pp. 392-6.
14. Harrington, WJ, Jr and Sheremata, W and Hjelle, B and Dube, DK and Bradshaw, P and Foung, SK and (1993) Spastic ataxia associated with human T-cell lymphotropic virus type II infection Ann Neurol, 33, pp. 411-4.
15. Casoli, C and Turci, M and Pilotti, E and Ciancianaini, P and Bertazzoni, U. (2003) Epidemiological and molecular data on 170 HTLV-II cases of Italian IDU AIDS Res Hum Retrovirology, 19, pp. S7.
16. Visconti, A and Visconti, L and Bellocco, R and Binkin, N and Colucci, G and Vernocchi, L and (1993) HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users J Acquir Immune Defic Syndr, 6, pp. 1228-37.
17. Hershow, RC and Galai, N and Fukuda, K and Graber, J and Vlahov, D and Rezza, G and (1996) An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users J Infect Dis, 174, pp. 309-17.
18. Bessinger, R and Beilke, MA and Kissinger, P and Jarrott, C and Tabak, OF. (1997) Retroviral coinfections at a New Orleans HIV outpatient clinic J Acquir Immune Defic Syndr, 14, pp. 67-71.
19. Harrison, LH and Vaz, B and Taveira, DM and Quinn, TC and Gibbs, CJ and de Souza, SH and (1997) Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV Neurology, 48, pp. 13-8.
20. Toro, C and Bassani, S and Rios, P and Jimenez, V and Camino, N and Soriano, V. (2005) Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients J Clin Virol, 32, pp. 338-9.
21. Hisada, M and Chatterjee, N and Zhang, M and Battjes, RJ and Goedert, JJ. (2003) Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T-lymphotropic virus type II J Infect Dis, 188, pp. 891-7.
22. Hagan, H and Thiede, H. (2000) Changes in injection risk behavior associated with participation in the Seattle needle-exchange program J Urban Health, 77, pp. 369-82.
23. Hagan, H and McGough, JP and Thiede, H and Weiss, NS and Hopkins, S and Alexander, ER. (1999) Syringe exchange and risk of infection with hepatitis B and C viruses Am J Epidemiol, 149, pp. 203-13.
24. Schmid, DS and Brown, DR and Nisenbaum, R and Burke, RL and Alexander, D and Ashley, R and (1999) Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2 J Clin Microbiol, 37, pp. 376-9.
25. Hjelle, B and Cyrus, S and Swenson, SG. (1992) Evidence for sexual transmission of human T- lymphotropic virus type II Ann Intern Med, 116, pp. 90-1.
26. Roucoux, DF and Wang, B and Smith, D and Nass, CC and Smith, J and Hutching, ST and (2005) A prospective study of sexual transmission of human T-lymphotropic virus (HTLV)-I and HTLV-II J Infect Dis, 191, pp. 1490-7.
27. Evans, JL and Hahn, JA and Page-Shafer, K and Lum, PJ and Stein, ES and Davidson, PJ and (2003) Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study) J Urban Health, 80, pp. 137-46.
28. Holmgren, B and Andersson, S and Harding, E and Schim van der Loeff, M and Vastrup, P and Aaby, P and (2002) Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau J Acquir Immune Defic Syndr, 30, pp. 342-50.
29. Holmgren, B and da Silva, Z and Larsen, O and Vastrup, P and Andersson, S and Aaby, P. (2003) Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau Aids, 17, pp. 241-53.
30. Henrard, DR and Soriano, V and Robertson, E and Gutierrez, M and Stephens, J and Dronda, F and (1995) Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group J Clin Microbiol, 33, pp. 1735-8.
31. Soriano, V and Vallejo, A and Gutierrez, M and Tuset, C and Cilla, G and Martinez-Zapico, R and (1996) Epidemiology of human T-lymphotropic virus type II (HTLV-II) infection in Spain. HTLV Spanish Study Group Eur J Epidemiol, 12, pp. 625-9.
32. Zunt JR, La Rosa A, Lama JR, Sanchez JL. HTLV-I and -II in high risk populations in PeruIn: 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Miami, 2004.